Welcome to the February issue. Upfront investigates antibiotic pollution in the supply chain, a “pharmtastic” voyage, and the impact of cannabis legalization on pharma. In our cover feature, we speak with Martin Van Trieste and Mark Paxton from Rx-360 about how to better protect patients through supply chain security. NextGen explores checkpoint inhibitors, and in business, George Chressanthis explains what Donald Trump’s policies may mean for pharma. We also sit down with Catherine Bollard, President of the International Society for Cellular Therapy (ISCT).
February 24, 2017
We track the rapid rise of single use systems – and explore their role in the biomanufacturing facility of the futureWe track the rapid rise of single use systems – and explore their role in the biomanufacturing facility of the future
1 min read
February 23, 2017
Six Sigma has the potential to deliver real cost savings by improving productivity and reducing defects, but making the change is challenging. Here are the essential steps to getting it right.
1 min read
February 23, 2017
Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion. Perfusion offers many benefits to bioprocessing, but choosing the right system and the right medium are key.Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion. Perfusion offers many benefits to bioprocessing, but choosing the right system and the right medium are key.
1 min read
February 23, 2017
Therapeutic modulation of checkpoint signals is bringing new treatments to cancer patients – and the industry is scrambling to find more.
1 min read
February 23, 2017
Brian Chekal wears two hats; one at Pfizer, where he is a senior principal scientist, and another at the American Association of Pharmaceutical Scientists (AAPS), where he chairs the Chemical and Biological API Manufacturing Technology focus group.
1 min read
February 23, 2017
1 min read
February 23, 2017
Donald Trump has vowed to bring down drug prices, but his policies in other areas, such as tax reforms and labor immigration, could also impact the pharma industry.
1 min read
February 23, 2017
“Rx-360 was created as part of an emotional reaction to the home truth that criminals were violating our industry. My wish was to use the upwelling of strong sentiment to drive positive change.”
1 min read
February 23, 2017
Biologics are expensive, but so too are biosimilars. Could local manufacturers based in Russia and other emerging markets, with their inherently lower costs, be well placed to develop cheaper biopharmaceuticals to benefit public health?
1 min read
February 22, 2017
We need to get better at predicting the real-world efficacy of vaccines. Human challenge studies are one possible way of achieving this.
1 min read
February 22, 2017
Every dosage form has its advantages – and we all have our preferences, either as formulators, manufacturers or consumers. But for modern medicines, I believe that liquid-filled encapsulation has the edge.
1 min read
February 22, 2017
We need to engage with patients more. What better way than partnering with Marvel Custom Solutions to create a graphic novel that depicts patients as “Super Heroes”?
1 min read
February 22, 2017
When it comes to marketing, pharma usually targets patients and the healthcare community. What about contract manufacturing organizations who market their services to other businesses?
1 min read
February 22, 2017
Sitting Down With... Catherine Bollard, President of the International Society for Cellular Therapy (ISCT).
1 min read
February 22, 2017
Beating the backlog, a campaign to counter criticism, and a first foray into biosimilars… What’s new for pharma in business?
1 min read
February 22, 2017
Scientists develop a microscopic “submarine” that neutralizes gastricacid for fuel to safely deliver drugs to the stomach
1 min read
February 22, 2017
What does the legalization of medical cannabis mean for conventional pharmaceuticals?
1 min read
February 22, 2017
An art gallery at Pharmapack showcased the artistic side of primary drug delivery devices.
1 min read
February 22, 2017
Pharma is urged to tackle the problem of polluted waste water from manufacturing plants – before antibiotics suffer
1 min read
February 22, 2017
PhRMA and the ABPI showcase the industry’s good side and the science behind the logo
1 min read
